期刊文献+

阿托伐他汀对高血压合并高血脂患者炎症因子的影响 被引量:10

The Effect of Atorvastatin on Inflammatory Factors in Hypertensive Patients with Hyperlipidemia
下载PDF
导出
摘要 目的探讨阿托伐他汀对高血压合并高血脂患者炎症因子的影响。方法入选62例高血压合并高血脂患者,在常规降压治疗基础上加服阿托伐他汀20mg,睡前服用,1次/d。另入选58例单纯高血压患者和60例正常体检者分别为单纯高血压组和正常对照组。治疗时间12周。检测治疗前后3组研究对象血压、血脂、超敏C反应蛋白(hsCRP)、白介素-1(IL-1)、白介素-6(IL-6)等因素的变化。结果治疗前高血压合并高血脂组的血压和血脂明显高于正常对照组,经降脂和降压治疗后血压与血脂显著下降(P<0.05)。高血压合并高血脂组各炎症因子的水平明显高于单纯高血压组和正常对照组(P<0.05),阿托伐他汀治疗后各炎症因子的水平显著下降(P<0.05)。结论阿托伐他汀可改善高血压合并高血脂患者的炎症状态。 Objective To study the effects of atorvastatin on inflammatory factors in hypertensive patients with hyperlipidemia. Methods 62 hypertensive patients with hyperlipidemia received conventional antihypertensive therapy and the treatment of atorvastatin 20 mg(QN). 58 simple hypertensive patients and 60 normal subjects were served as control group.The changes of blood pressure、lipids、hsCRP、IL-1 and IL-6 were measured before and after 12 weeks treatmemt.Results The level of blood pressure and lipid in atorvastat...
作者 刘镜泉
出处 《中外医疗》 2008年第20期20-21,23,共3页 China & Foreign Medical Treatment
关键词 阿托伐他汀 高血压 高血脂 炎症因子 Atorvastatin Hypertension Hyperlipidemia Inflammatory factors
  • 相关文献

参考文献13

  • 1吴进寿,洪华山.高血压与炎症关系的研究进展[J].中国临床药理学与治疗学,2006,11(2):136-140. 被引量:47
  • 2[2]Makin AJ,Blann AD,Chung NA,et al.Assessment of endot-helial damage in atherosclerotic vascular diSease by quanti-fication of circulating endothelial cells relationship with von Willebrand factor and tissue factor[J].Eur Heart J,2004,25(5):3741~373.
  • 3[3]Albert MA,Danielson E,Rifai N,et al.Effect of statins therapy on creactive protein levels.the pravastatin infammatory/CRP evaluation(PRNCE):a randomized trial and cohort study[J].JAMA,2001,286(I):64~70.
  • 4李呐,邓海,夏小杰.他汀类药物与高血压[J].实用医技杂志,2004,11(07B):1303-1305. 被引量:7
  • 5[5]Hayaishi-Okano R,Yamasaki Y,Katakami N,ct el.Elevated C-reactive protein associates with early stage carotid ath erosclerosis in young subjects with type 1 diabets[J].Diabe-tes Care,2002,25(10).1432~1438.
  • 6龚艺,徐劲松,苏海,王卫.他汀类药物对高胆固醇血症患者炎症因子和红细胞膜脂肪酸的影响[J].中国实用内科杂志,2007,27(3):193-195. 被引量:21
  • 7[7]Kureishi Y,luo Z,Shiojilma I,et al.The HMG-CoA reduc-tase inhibitor sirastatin activatcs the protein kinase AKt and promotes angiogenesis in normocholestrmic animels[J].Nat Med,2000,6(10):1004~1010.
  • 8杨永超,周若锋.高血压病患者血清Hs-CRP的变化及辛伐他汀的干预作用[J].江西医药,2007,42(1):29-31. 被引量:5
  • 9李建军.高血压可能是一种炎症相关性疾病[J].高血压杂志,2005,13(9):526-527. 被引量:46
  • 10[10]Fichtlscherer S,Rosenberger G,Walter DH,et al.Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease[J].Circulation,2000,102(11):1000~1006.

二级参考文献65

  • 1朱建华,邱立红,张必祺,孙坚.不同剂量辛伐他汀治疗对急性冠状动脉综合征患者几种炎症因子的影响[J].中华心血管病杂志,2004,32(11):972-976. 被引量:34
  • 2朱健,陈谊,王曹峰,马绍骏,苏海霞.细胞因子与高血压病患者左室构型的相关性研究[J].中华老年心脑血管病杂志,2005,7(3):166-168. 被引量:4
  • 3吕萍,李自成,常青.C反应蛋白与高血压病、冠心病关系的临床研究[J].西安交通大学学报(医学版),2005,26(5):447-449. 被引量:27
  • 4庞新权,倪新海,牛文革,李民,周金贵,陈振峰,胡曙云.氟伐他汀对高脂血症患者血浆CRP的影响[J].中国医师杂志,2005,7(11):1578-1579. 被引量:1
  • 5Laufs U,Gertz K,Huang P,et al.Atorvastatin upregulates type III nitric oxide synthase in thrombocytes,decreases platelet activation,and protects from cerebral ischemia in normocholesterolemic mice[J].Stroke,2000,31(10):2442-2449
  • 6Undas A,Brummel KE,Musial J,et al.Simvastatin depresses blood clotting by inhibiting activation of prothrombin,factor V,and factor XIII and by enhancing factor Va inactivation[J].Circulation,2001,103(18):2248-2253
  • 7Werner N,Priller J,Laufs U,et al.Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation:effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition[J].Arterioscler Thromb Vasc Biol,2002,22(10):1567-15
  • 8Li D,Chen H,Romeo F,et al.Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells:role of LOX-1[J].J Pharmacol Exp Ther,2002,302(2):601-5
  • 9Silva EP,Fonseca FA,Ihara SS,et al.Early benefits of pravastatin to experimentally induced atherosclerosis[J].J Cardiovasc Pharmacol,2002,39(3):389-395
  • 10Wassman S,Faul A,Hennen B,et al.Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function[J].Circ Res,2003,93(9):e98-e103

共引文献162

同被引文献109

引证文献10

二级引证文献145

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部